News on health and wellness in Finland
Provided by AGP
AGP Picks
View all
Perspectify News
Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Filter
Press releases
Publish your press release
May. 4, 2026
Thai University Approves Helsinki-Standard Study of Maha Taksa Astrology Tradition
EIN Presswire
Mae Fah Luang University's Human Research Ethics Committee has approved a qualitative study of Maha Taksa, the Thai astrology system, under Helsinki standards.
an hour ago
Optivian opens its AI sales co-worker to any AI agent through MCP
EIN Presswire
Sales teams can now reach Ollie's deal context and work product from inside Claude, ChatGPT, Cursor, and Copilot HELSINKI, FINLAND, May 5, 2026 /EINPresswire.com/ -- Optivian, the company behind AI sales co-worker Ollie, today announced that...
Apr. 28, 2026
Finland Causations of Increasing Strain on Country’s Public Finances
MENAFN
(MENAFN) Finland’s finance minister Riikka Purra has raised concerns about increasing strain on the country’s public finances, shortly after the government introduced a long-term fiscal plan that pairs higher military assistance to Ukraine with...
Apr. 30, 2026
Gluten-Free Products Market Gaining Momentum with Health-Driven Consumer Trends
GlobeNewswire, Inc.
Delray Beach, FL, April 30, 2026 (GLOBE NEWSWIRE) -- The global gluten-free products market is experiencing steady expansion as consumers increasingly shift toward healthier and more personalized dietary choices.
Apr. 23, 2026
Orion Pharma initiates TEADCO Phase 1b/2 basket trial evaluating ODM-212 in combination with standard of care treatments in patients with select advanced solid tumours
GlobeNewswire, Inc.
ORION CORPORATION PRESS RELEASE 23 APRIL 2026 at 09.00 EEST Orion Pharma initiates TEADCO Phase 1b/2 basket trial evaluating ODM-212 in combination with standard of care treatments in patients with select advanced solid tumours Orion Corporation...
Apr. 20, 2026
Orion Pharma’s ODM-212 Granted Orphan Drug Designation in Mesothelioma by the US FDA
GlobeNewswire, Inc.
ORION CORPORATION PRESS RELEASE 20 APRIL 2026 at 16.00 EEST Orion Pharma’s ODM-212 Granted Orphan Drug Designation in Mesothelioma by the US FDA Orion Corporation (Orion Pharma) today announced that its investigational drug ODM-212 has received...
Video Stories
Sign up for Health Daily Finland.
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.
Explore More
